Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;5(3):327-331.
doi: 10.3892/br.2016.732. Epub 2016 Aug 1.

Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi

Affiliations

Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi

Jianxin Xia et al. Biomed Rep. 2016 Sep.

Abstract

Malignant melanoma (MM) is a type of malignant tumor, which originates from neural crest melanocytes. MM progresses rapidly and results in a high mortality rate. The present study aims to investigate the expression of microphthalmia transcription factor (MITF), the S100 protein, and HMB-45 in MM and pigmented nevi. A total of 32 MM samples (including three skin metastasis, three lymph node metastasis and two spindle cell MM samples), two Spitz nevus samples, four pigmented nevus samples and two blue nevus samples were collected. The expression levels of S100 protein, HMB-45, and MITF were observed via immunostaining. The S100 protein exhibited high positive rates in MM and pigment disorders (96.7 and 100%, respectively), but with low specificity. The S100 protein was also expressed in fibroblasts, myoepithelial cells, histocytes and Langerhans cells in normal skin samples. HMB-45 had high specificity. Its positive expression was only confined to MM cells and junctional nevus cells. Furthermore, HMB-45 was not expressed in melanocytes in the normal tissue samples around the tumor or in the benign intradermal nevus cells. MITF exhibited high specificity and high sensitivity. It was expressed in the nuclei of melanocytes, MM cells and nevus cells. It was observed to be strongly expressed in metastatic MM and spindle cell MMs. Thus, MITF may present as a specific immunomarker for the diagnosis and differential diagnosis of MM.

Keywords: Spitz nevus; lymph node metastasis; malignant melanoma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Expression of S100 protein, HMB-45, and MITF in MM and pigmented nevus samples. (A) S100 protein in MM (+++; magnification, ×200); (B) HMB-45 in MM (magnification, ×400); (C) HMB-45 in Spitz nevus (+++; magnification, ×200); (D) MITF in MM (+; magnification, ×100); (E) MITF in metastatic MM (+; magnification, ×100); (F) MITF in Spitz nevus (+; magnification, ×100). MITF, microphthalmia transcription factor; MM, malignant melanoma.
Figure 2.
Figure 2.
Unspecific staining of S100 protein in hair follicles, sweat glands and fibroblasts (magnification, ×400).
Figure 3.
Figure 3.
Expression of S100 protein in pigmented nevus, blue nevus, and Spitz nevus samples. S100 protein in (A) pigmented nevus, (B) blue nevus and (C) Spitz nevus (magnification, ×400).
Figure 4.
Figure 4.
HMB-45 expression in normal Langerhans cells without skin damage caused by melanoma (magnification, ×400).

Similar articles

Cited by

References

    1. Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: Epidemiology, risk factors, pathogenesis, diagnosis and classification. Vivo. 2014;28:1005–1011. - PubMed
    1. National Collaborating Centre for Cancer. Melanoma: Assessment and management. National Institute for Health and Care Excellence; London: 2015. - PubMed
    1. Tripp MK, Watson M, Balk SJ, Swetter SM, Gershenwald JE. State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now. CA Cancer J Clin. 2016 May 27; doi: 10.3322/caac.21352. (Epub ahead of print) - DOI - PMC - PubMed
    1. Hoek KS, Eichhoff OM, Schlegel NC, Döbbeling U, Kobert N, Schaerer L, Hemmi S, Dummer R. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 2008;68:650–656. doi: 10.1158/0008-5472.CAN-07-2491. - DOI - PubMed
    1. Scolyer RA, Li LX, McCarthy SW, Shaw HM, Stretch JR, Sharma R, Thompson JF. Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens. Melanoma Res. 2004;14:263–268. doi: 10.1097/01.cmr.0000136708.90534.71. - DOI - PubMed